BGI and Danish Researchers Sequence 200 Exomes, Uncover More Deleterious Rare Variants than Expected

The study, whose results lend support to the rare variant hypothesis of disease, is part of a larger collaboration between BGI and the University of Copenhagen that will use exome sequencing to study metabolic disease.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.